Anchor Investment Management’s West Pharmaceutical WST Stock Holding History

Anchor Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.1K	Buy	187 +174	+1,338%	+$53.2K	0.01%	566
2026 Q1	$3.26K	Hold	13	–	–	﹤0.01%	942
2025 Q4	$3.58K	Hold	13	–	–	﹤0.01%	925
2025 Q3	$3.41K	Hold	13	–	–	﹤0.01%	936
2025 Q2	$2.84K	Sell	13 -23	-64%	-$4.92K	﹤0.01%	933
2025 Q1	$8.06K	Hold	36	–	–	﹤0.01%	823
2024 Q4	$11.8K	Hold	36	–	–	﹤0.01%	773
2024 Q3	$10.8K	Hold	36	–	–	﹤0.01%	771
2024 Q2	$11.9K	Hold	36	–	–	﹤0.01%	720
2024 Q1	$14.2K	Buy	36 +23	+177%	+$8.51K	﹤0.01%	722
2023 Q4	$4.58K	Hold	13	–	–	﹤0.01%	824
2023 Q3	$4.88K	Hold	13	–	–	﹤0.01%	833
2023 Q2	$4.97K	Hold	13	–	–	﹤0.01%	827
2023 Q1	$4.5K	Hold	13	–	–	﹤0.01%	844
2022 Q4	$3.06K	Hold	13	–	–	﹤0.01%	849
2022 Q3	$3.2K	Hold	13	–	–	﹤0.01%	852
2022 Q2	$3.93K	Hold	13	–	–	﹤0.01%	841
2022 Q1	$5.34K	Hold	13	–	–	﹤0.01%	832
2021 Q4	$6.1K	Buy	+13	New	+$5.6K	﹤0.01%	850

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Anchor Investment Management's WST Position: Q2 2026 in Review

Anchor Investment Management increased its West Pharmaceutical (WST) stake by 1,338% in Q2 2026, buying an estimated $53.2K and bringing the position to 187 shares worth $67.1K. The position accounts for 0.01% of the portfolio, ranked #566.

Anchor Investment Management first reported a position in WST in Q4 2021 and has held it in 19 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Anchor Investment Management held 187 shares of West Pharmaceutical worth $67.1K as of Q2 2026.
Anchor Investment Management bought 174 West Pharmaceutical shares in Q2 2026, an estimated $53.2K.
West Pharmaceutical made up 0.01% of Anchor Investment Management's portfolio in Q2 2026, its #566 holding.
Anchor Investment Management first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Anchor Investment Management's 13F filing for Q2 2026, filed 15 Sep 2026.